Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD30 in Normal and Neoplastic Cells

1 Feb 1999

Abstract excerpt

In 1982 Stein and coworkers identified a new molecule, CD30 (Ki-1), which is expressed by Reed-Sternberg (RS) cells of Hodgkin's Disease (HD) (1). Although CD30 is not a specific RS cell marker, its characterization has assumed an important role not only in the differential diagnosis of HD, but also in the identification of a morphologically and clinically distinct type of large cell lymphoma, now designated as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Immune Cell Function and Interaction
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10080826
DOI: 10.1006/clim.1998.4636

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD30 in Normal and Neoplastic CellsPMID 10080826Read ↗

Mechanism of action and therapeutic targeting of CD30 molecule in lymphomasSemantic proximity Read ↗

Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30)Semantic proximity Read ↗

CD30—Governor of Memory T Cells?Semantic proximity Read ↗

Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells.Semantic proximity Read ↗

Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns?Semantic proximity Read ↗

Primary systemic anaplastic large-cell lymphoma (CD30+): advances in biology and current therapeutic approaches.Semantic proximity Read ↗

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.Semantic proximity Read ↗

Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.Semantic proximity Read ↗

Primary Cutaneous CD30 positive Lymphoproliferative Disorders—Current Therapeutic Approach with Focus on Brentuximab VedotinSemantic proximity Read ↗

[Adult's anaplastic CD30+ large cell lymphomas].Semantic proximity Read ↗

Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.Semantic proximity Read ↗

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.